Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Phenox is a leading medical technology company specializing in the development and manufacture of innovative neurovascular devices for the treatment of stroke and other neurovascular diseases. Founded in 2005 and headquartered in Bochum, Germany, the company offers a comprehensive portfolio of products including flow diverters, stent retrievers, and bifurcation stents designed to improve clinical outcomes in interventional neuroradiology. Its flagship products, such as the p64 and p48 flow diverters and the pRESET stent retriever, are widely used by neurointerventionalists globally. In 2022, Phenox was acquired by Wallaby Medical to create a global leader in neurovascular solutions, combining their respective technologies to address the full spectrum of stroke care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fenox.